Ceftin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ceftin

What is Ceftin? (Cefuroxime)

Property Description
Active ingredient Cefuroxime Axetil (Prodrug)
Form Tablet, Oral suspension
Pharmacological class Second-generation Cephalosporin Antibiotic
General purpose Systemic bacterial infection management
Origin Semi-synthetic

Ceftin: Identity and Classification

Ceftin is a prescription-only antibacterial agent primarily used to address systemic bacterial infections. Its active component is Cefuroxime Axetil, and it belongs to the class of second-generation cephalosporin antibiotics. Ceftin is a semi-synthetic drug, meaning it is chemically synthesized from the naturally derived cephalosporin core structure. This classification as a second-generation agent is clinically recognized for its expanded spectrum of activity compared to older cephalosporins, allowing it to target a broader, targeted range of susceptible bacteria, which is integral to its efficacy in managing common issues like respiratory tract infections.


Composition, Form, and General Purpose

The active substance in Ceftin is Cefuroxime, which is administered orally as the prodrug, Cefuroxime Axetil. This specific formulation is essential because the Axetil ester modification facilitates enhanced and reliable absorption from the gastrointestinal tract, enabling the oral route of administration. Ceftin is available in two main oral dosage forms: a solid tablet and a liquid oral suspension. The general purpose of this single active ingredient product is to actively eliminate bacterial pathogens. Cefuroxime is recognized as a bactericidal agent, meaning it works by directly killing the susceptible bacteria through interference with their ability to build structural cell walls. This confirms the medicine offers a definitive, microbe-eradicating action against the infectious disease.

What side effects are possible with Ceftin?

Official Adverse Reaction Profile

The safety profile for Ceftin (Cefuroxime Axetil) is formally defined by regulatory authorities based on classification by frequency and affected system-organ class. Common side effects (ge 1/100 to <1/10) include gastrointestinal effects such as diarrhea, nausea, and vomiting, along with headache and dizziness. Other commonly listed effects are changes in laboratory investigations, such as eosinophilia and transient increases in hepatic enzyme levels, as well as candidal overgrowth.

Serious Adverse Reactions

Regulatory documents list several serious adverse reactions. These include severe immediate hypersensitivity reactions such as anaphylaxis and severe cutaneous adverse reactions like Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The medication carries a documented risk for Pseudomembranous colitis and Clostridioides difficile-associated diarrhea (CDAD). Furthermore, neurological effects, including seizure and encephalopathy, are listed, particularly when used in the context of high systemic concentrations.

Population and Safety Constraints

The medicine's half-life is prolonged in patients with renal impairment, which is a safety consideration for all patients with reduced renal function. The oral suspension formulation contains phenylalanine, which is a specific constraint for patients with Phenylketonuria (PKU). The acute Jarisch-Herxheimer reaction is an officially documented time-related pattern following the initiation of treatment for Lyme disease. The drug also interferes with specific diagnostic tests, resulting in a positive Coombs’ test and false results for certain urinary glucose tests.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Ceftin (cefuroxime axetil) overdose is strictly defined by the potential for high drug concentrations in the body, primarily affecting the Central Nervous System (CNS).


Documented Manifestations and Actions

Excessive amounts of Ceftin, particularly in cases of overdose, can lead to signs of CNS excitation and seizures.

Category Regulatory Statement
Primary CNS Risk CNS excitation; Seizures
Emergency Action Seek emergency medical attention or call a Poison Control Center at once
Antidote Information No specific antidote is available

Management and Population Considerations

Treatment for a suspected overdose is symptomatic and supportive. Regulatory documents state that both hemodialysis and peritoneal dialysis can effectively remove cefuroxime from the system.

Patients with reduced renal function are noted to have a prolonged cefuroxime half-life. This accumulation risk necessitates careful monitoring in this population and highlights a predisposition to drug toxicity at concentrations that could otherwise be cleared more readily.

In all cases of suspected overdose, medical professionals should be contacted immediately.

Therapeutic Uses of Ceftin

What Ceftin Treats: Main Uses and Benefits

Ceftin (Cefuroxime Axetil) is an oral cephalosporin antibiotic used to manage bacterial infections, and is generally applied across domains where additional symptomatic support is needed. The medication is associated with targeting the bacterial cause, which generally supports symptomatic relief and a reduction in discomfort.


Key Therapeutic Focus

The medication is relevant for a range of conditions presenting with acute or disruptive episodes. It is commonly used to help with certain distressing symptoms, generally applied in situations involving respiratory infections like community-acquired pneumonia and acute exacerbations of chronic bronchitis; ENT infections such as acute otitis media and bacterial sinusitis; and specific localized infections, including uncomplicated skin structure infections and early Lyme disease.

Ceftin contributes to easing the overall symptom load, and may help patients cope more steadily with symptoms that interfere with daily functioning, like fever, earache, or painful swallowing. “The goal of therapy is to provide support that helps ease the overall symptom burden in conditions involving inflammatory or irritative processes.”


QuickFact

Quick Fact: Symptomatic Support for Acute Discomfort
Ceftin is commonly used when symptoms related to inflammatory or irritative states in the ears, sinuses, or throat become disruptive, and is relevant for easing localized pain and pressure.

Regulatory References

  1. FDA-Approved Prescribing Information via NIH DailyMed

Eligibility and Restrictions for Use

Ceftin (cefuroxime axetil) is an antibiotic prescribed to treat a range of bacterial infections in adults and pediatric patients generally aged 3 months and older. It is not effective against viral infections, such as the common cold or flu.

Contraindications

Ceftin is contraindicated in patients with a history of a known allergy or severe hypersensitivity reaction to cefuroxime, other cephalosporin antibiotics (a class of drugs that includes Ceftin), or any other beta-lactam antibacterial drugs.

Patients with a history of penicillin allergy, especially those who have experienced severe reactions like anaphylaxis, should use Ceftin with extreme caution. While the risk of cross-reactivity is considered low, it is still necessary to inform a healthcare professional about any past allergic reactions to penicillin or other antibiotics.

Precautions and Specific Populations

Certain medical conditions or patient groups require careful consideration and potential dose adjustment before using Ceftin:

  • Kidney or Liver Impairment: Patients with reduced kidney or liver function may require a lower dose, as the drug may be cleared more slowly from the body.
  • Gastrointestinal Disease: Caution is advised for those with a history of gastrointestinal disease, particularly colitis, as antibiotic use can sometimes worsen these conditions.
  • Pregnancy and Breastfeeding: While cephalosporins are generally considered safe during pregnancy, Ceftin should only be used if the potential benefit justifies the potential risk. Ceftin is excreted in breast milk; consult a healthcare professional, as low levels are generally not expected to cause severe adverse effects in the infant, though minor effects like diarrhea may occur.
  • Phenylketonuria (PKU): The oral suspension formulation contains phenylalanine and must be used with caution in individuals with PKU.

What should I know about interactions with other medicines?

Ceftin (Cefuroxime Axetil) has officially documented interaction patterns primarily concerning drug exposure, certain pharmacodynamic effects, and interference with laboratory diagnostics. All documented interaction information is sourced from government regulatory documents.

Drug–Drug and Substance Interactions

Interacting Substance/Product Official Interaction Pattern Formal Regulatory Restriction
Probenecid Co-administration significantly increases systemic exposure to Cefuroxime (Cmax and AUC). Not Recommended
Acid-Reducing Agents Drugs that reduce gastric acidity (e.g., antacids, H2-receptor antagonists) may lower the bioavailability of Cefuroxime Axetil. Avoid H2-antagonists/PPIs
Oral Anticoagulants Concomitant use may lead to increased International Normalized Ratio (INR). Special note for renal/hepatic impairment
Oral Contraceptives May affect gut flora, leading to lower oestrogen reabsorption and reduced efficacy. Efficacy risk documented
Peristalsis Inhibitors Should not be given if Clostridioides difficile-associated diarrhea (CDAD) is suspected. Should not be given

Timing and Procedural Constraints

Regulatory labeling documents specific timing conditions for absorption-related interactions: short-acting antacids are to be administered at least one hour before or two hours after Cefuroxime Axetil.

Furthermore, Cefuroxime is documented to interact with medical diagnostic procedures: it may cause a false-positive reaction for glucose in the urine with copper reduction tests and can cause a false-negative result with ferricyanide tests. Its use is also associated with a positive Coombs Test.

Mechanism of Action

Ceftin (Cefuroxime) exerts a highly targeted mechanism known as bactericidal action, which relies solely on disrupting the structural integrity of the bacterial cell. This process begins with the drug acting as a covalent inhibitor of crucial bacterial enzymes called Penicillin-Binding Proteins (PBPs), specifically PBP1 and PBP3.

These PBPs are indispensable for the transpeptidation process, which is the final step in synthesizing the rigid peptidoglycan framework of the bacterial cell wall. By irreversibly blocking PBP function, Cefuroxime halts cell wall construction, causing structural destabilization. This failure leads to the activation of the bacterium's own autolytic enzymes, which degrade the compromised structure. The cascade culminates in an immediate and irreversible loss of the cell's osmotic integrity, resulting in the lysis (rupture) and death of the susceptible bacteria.

Furthermore, Cefuroxime's structure provides mechanistic resistance to inactivation by certain common beta-lactamase enzymes. This stability ensures the drug maintains its ability to reach and inhibit the PBP target against bacterial strains that produce these defensive enzymes.

Dosage and Administration Information

How to Use Ceftin

Ceftin (Cefuroxime Axetil) is administered through the oral route, available in both tablet and oral suspension dosage forms for systemic use. The administration protocol is structured by specific instructions regarding timing, form handling, and patient physiology. The standard regimen for most adult infections involves a twice-daily frequency (every 12 hours) over a course duration that typically ranges from 5 to 10 days, although treatment for early Lyme disease is extended to 20 days.


Administration Conditions

Condition Official Use Principle
Timing with Food The oral suspension must be administered with food for optimal absorption; tablets may be taken with or without food.
Tablet Handling Tablets must be swallowed whole and should not be crushed, broken, or chewed.
Renal Impairment Dosage adjustment is required for adult patients with significantly reduced kidney function (creatinine clearance <30 mL/min); the dosing interval may extend to every 24 or 48 hours.
Formulation Equivalence The tablet and oral suspension formulations are not substitutable on a milligram-for-milligram basis.

Standard Dosing Regimens

Most adult multi-day dosing involves either a 250 mg every 12 hours or a 500 mg every 12 hours regimen. For uncomplicated gonorrhea, the labeled dosage is a 1,000 mg single dose. If a dose is missed, it should be taken as soon as possible unless the time for the next scheduled dose is near, in which case the patient should not take a double dose. These instructions define the standardized approach to using the medicine.

Recent Clinical Evidence

Cefuroxime axetil, a second-generation cephalosporin, is an antibacterial agent used in the treatment of a range of infections. Clinical research focuses on its utility against common community-acquired pathogens, particularly those affecting the respiratory tract, skin, and urinary tract.

Efficacy in Common Infections

Studies have examined the use of the drug for bacterial infections such as pharyngitis/tonsillitis, acute bacterial sinusitis, and uncomplicated skin and urinary tract infections.

  • Respiratory Studies: Research supports its role in managing acute exacerbations of chronic bronchitis. Comparative trials have explored shorter course regimens (e.g., 5 days) for certain respiratory infections, with findings indicating comparable clinical outcomes to longer standard treatments.
  • Sequential Therapy: Evidence supports the practice of sequential therapy for hospitalized patients with Community-Acquired Pneumonia (CAP), involving an initial course of intravenous cefuroxime followed by a switch to the oral cefuroxime axetil tablet or suspension.

Microbiological Activity and Resistance

Cefuroxime is recognized for its stability against many beta-lactamase enzymes, providing coverage against various Gram-positive and Gram-negative bacteria, including strains of Haemophilus influenzae and Streptococcus pneumoniae. However, clinical research emphasizes that the drug is not effective against atypical pathogens or certain highly resistant bacteria like Methicillin-Resistant Staphylococcus aureus (MRSA), highlighting the need to consider local susceptibility patterns.

Safety and Pharmacological Insights

Safety data compiled from clinical trials indicate that the most commonly reported adverse events are gastrointestinal disturbances (such as diarrhea and nausea/vomiting), which are typically mild to moderate. Pharmacokinetic studies have also shown that the oral suspension and tablet forms are not bioequivalent, a factor that is considered in establishing appropriate dosage for different patient populations.

Key Studies & References

  1. CEFUROXIME AXETIL Tablets and Oral Suspension Prescribing Information

Frequently Asked Questions (FAQ)

Common questions about Ceftin (FAQ)


Q: What is the maximum daily dose of Ceftin for an adult?

Official regulatory documents note that a maximum recommended daily dosage of 1000 mg is used in many adult treatment regimens. For example, some common uses involve a twice-daily 500 mg regimen. The specific single dose recommended for uncomplicated gonorrhea is 1000 mg.


Q: How quickly does Ceftin start working for an infection?

Regulatory studies on the drug's absorption indicate that the tablet form is converted to the active drug, Cefuroxime, relatively quickly. Peak levels in the bloodstream are typically reached about 2 to 3 hours after a dose is taken. This absorption profile allows the drug to become active in the bloodstream to target susceptible bacteria.


Q: What are the signs of a serious allergic reaction to Ceftin that require immediate medical help?

Ceftin is associated with a risk of severe allergic reactions, which are officially known as hypersensitivity reactions. Signs that are consistent with a severe reaction and should be discussed urgently with a healthcare professional may include hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.


Q: What is the brand name of generic Cefuroxime Axetil?

Cefuroxime Axetil is the generic name for the active ingredient. Ceftin is a common brand name for this medicine in its oral form. Other brand names exist for different formulations of Cefuroxime, such as the injectable version (e.g., Zinacef).


Q: Can I drive or operate machinery after taking this medicine?

Official safety data indicates that Ceftin can cause side effects, including dizziness. The presence of side effects like dizziness is a factor to consider when performing skilled tasks that require focus, such as driving or operating heavy machinery.

How should Ceftin be stored and disposed of?

How to Store and Dispose of Ceftin (Cefuroxime Axetil)

Official regulatory guidelines define specific storage requirements for Ceftin tablets and the oral suspension to maintain stability.

Storage Requirements

Dosage Form Required Storage Condition Stability/Handling Rules
Tablets Controlled Room Temperature (20 C to 25 C) Protect from moisture, heat, and light. Keep container tightly closed.
Reconstituted Suspension Refrigerated (2 C to 8 C) Must not be frozen. Discard the unused suspension after 10 days.

All forms of Ceftin must be stored out of the reach of children. Disposal of unused or expired medicine should follow governmental instructions, which typically recommend mixing the product with an unappealing substance and sealing it before discarding in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ceftin found in:

A-Z Index: